Donald R Endres, MD | |
3730 Rhone Cir, Ste 203, Anchorage, AK 99508-5051 | |
(907) 563-3515 | |
Not Available |
Full Name | Donald R Endres |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 32 Years |
Location | 3730 Rhone Cir, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952311425 | NPI | - | NPPES |
MD1661 | Medicaid | AK |
Facility Name | Location | Facility Type |
---|---|---|
South Peninsula Hospital | Homer, AK | Hospital |
Providence Alaska Medical Center | Anchorage, AK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ear Nose And Throat Specialists Alaska, Inc | 6204848294 | 11 |
News Archive
The HIV-1 virus cripples the human immune system by targeting white blood cells called T cells that form the body's first line of defense in fighting infections.
Virginia Tech released today results from the first study ever to instrument child football helmets. Youth football helmets are currently designed to the same standards as adult helmets, even though little is known about how child football players impact their heads.
The Wearable Technology Show – the world's biggest dedicated wearables event – opens its doors in London next Tuesday. With 110 exhibitors and nearly 200 speakers, the event has more than doubled in size since its launch last March and is already respected globally as the ultimate destination for everyone involved in wearables.
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today the completion of its New Drug Application (NDA) submission to the U.S. Food & Drug Administration (FDA) for OMAPRO™ (omacetaxine mepesuccinate). OMAPRO™ is being developed for the treatment of patients with chronic myeloid leukemia (CML) who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation.
› Verified 1 days ago
Entity Name | Ear Nose And Throat Specialists Alaska, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972552891 PECOS PAC ID: 6204848294 Enrollment ID: O20060609000194 |
News Archive
The HIV-1 virus cripples the human immune system by targeting white blood cells called T cells that form the body's first line of defense in fighting infections.
Virginia Tech released today results from the first study ever to instrument child football helmets. Youth football helmets are currently designed to the same standards as adult helmets, even though little is known about how child football players impact their heads.
The Wearable Technology Show – the world's biggest dedicated wearables event – opens its doors in London next Tuesday. With 110 exhibitors and nearly 200 speakers, the event has more than doubled in size since its launch last March and is already respected globally as the ultimate destination for everyone involved in wearables.
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today the completion of its New Drug Application (NDA) submission to the U.S. Food & Drug Administration (FDA) for OMAPRO™ (omacetaxine mepesuccinate). OMAPRO™ is being developed for the treatment of patients with chronic myeloid leukemia (CML) who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Donald R Endres, MD 3730 Rhone Cir, Ste 203, Anchorage, AK 99508-5051 Ph: (907) 563-3515 | Donald R Endres, MD 3730 Rhone Cir, Ste 203, Anchorage, AK 99508-5051 Ph: (907) 563-3515 |
News Archive
The HIV-1 virus cripples the human immune system by targeting white blood cells called T cells that form the body's first line of defense in fighting infections.
Virginia Tech released today results from the first study ever to instrument child football helmets. Youth football helmets are currently designed to the same standards as adult helmets, even though little is known about how child football players impact their heads.
The Wearable Technology Show – the world's biggest dedicated wearables event – opens its doors in London next Tuesday. With 110 exhibitors and nearly 200 speakers, the event has more than doubled in size since its launch last March and is already respected globally as the ultimate destination for everyone involved in wearables.
ChemGenex Pharmaceuticals Limited (ASX:CXS) announced today the completion of its New Drug Application (NDA) submission to the U.S. Food & Drug Administration (FDA) for OMAPRO™ (omacetaxine mepesuccinate). OMAPRO™ is being developed for the treatment of patients with chronic myeloid leukemia (CML) who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation.
› Verified 1 days ago
Dr. Jamie Swartz, DO Otolaryngology Medicare: Medicare Enrolled Practice Location: 673 Mdg/sghq, 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-1035 | |
Christopher Edward Kowalski, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St., Suite T-230, Anchorage, AK 99508 Phone: 907-279-8800 Fax: 907-279-8810 | |
Dr. Mark B. Lorenz, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3730 Rhone Cir Ste 203, Anchorage, AK 99508 Phone: 907-563-3515 Fax: 907-563-3541 | |
Dr. Laura Louise Shively, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anmc Otolaryngology Department, Anchorage, AK 99508 Phone: 907-729-1400 | |
Jack Arlyn Smith, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4001 Dale St, #201, Anchorage, AK 99508 Phone: 907-561-1185 | |
Dr. James E Kallman, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3841 Piper St, Suite T230, Anchorage, AK 99508 Phone: 907-279-8800 Fax: 907-279-8810 | |
Randall Leslie Plant, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508 Phone: 907-729-3971 Fax: 907-729-1542 |